Viatris Inc. entered into an underwriting agreement on June 12, 2026, to issue and sell €650,000,000 principal amount of 4.250% Senior Notes due 2033. BNP Paribas, Citigroup Global Markets Limited, and Goldman Sachs & Co. LLC are acting as representatives for the underwriters. The offering is expected to close on June 17, 2026. Viatris Inc. is a global healthcare company that develops and manufactures generic and branded pharmaceutical products.
